Stage I Ovarian Mesonephric-Like Adenocarcinoma With Mixed Müllerian Features

Patient Info: Anonymized, Female, 60s | Stage I

Biomarkers: KRAS p.; ARHGAP35 p.L1295Cfs*20; PPP2R1A p.; IRS1 p. in endometrioid and mesonephric-like areas; chromosome 1q gain

A 63-year-old woman underwent surgery for a 12 cm stage I ovarian mesonephric-like adenocarcinoma containing mixed mucinous and endometrioid components with shared molecular alterations.

PubMed CentralRead more →

Stage IV Ovarian Cancer: Melbey's Patient Story

Patient Info: Melbey Segovia, Female | Stage IV

Melbey Segovia died on May 4, 2021, about 5 years and 3 months after her February 2016 diagnosis, after three relapses and hospice care.

Dana-FarberRead more →

Stage III Ovarian Cancer: Jaclyn's Patient Story

Patient Info: Jaclyn (Jackie) VanRaaphorst | Stage III

Biomarkers: FRα-positive; CA-125 monitored

AACR later reported that Jackie died on January 16, 2025.

Ovarian Cancer: Jennifer's Patient Story

Patient Info: Jennifer Thorn, Female, 40s

Living with ovarian cancer and continuing gemcitabine after about 2 years of treatment.

Dana-FarberRead more →

Stage I BRCA1 Ovarian Cancer: Carol's Survivor Story

Patient Info: Carol Arnhart | Stage I

Biomarkers: BRCA1 mutation

After staging surgery and 6 rounds of carboplatin and paclitaxel, she reported no evidence of ovarian cancer.

MD AndersonRead more →

Stage I Ovarian Cancer: Elle's Patient Story

Patient Info: Elle Simone Scott, Female, Under 40 | Stage I

Living with recurrent ovarian cancer for more than 6 years after her September 2016 diagnosis, with an active clinical trial slowing progression at the May 2023 publication.

Dana-FarberRead more →

Stage IV Ovarian Cancer Complicated by Anti-Yo Cerebellar Degeneration

Patient Info: Anonymized, Female | Stage IV

Biomarkers: CA-125: 1767 kU/L; anti-Yo antibodies positive in serum and cerebrospinal fluid

Her anti-Yo paraneoplastic cerebellar degeneration progressed despite methylprednisolone and plasma exchange. Care became palliative, and she died 2 months after hospital admission.

PubMed CentralRead more →

Stage III Ovarian Cancer: Karoline's Patient Story

Patient Info: Karoline Strauss, female | Stage III

After resuming etigilimab and nivolumab, the patient felt markedly better; by the eighth infusion, some tumors had disappeared and others were shrinking, and treatment was continuing.

MD AndersonRead more →

Stage IIIC Ovarian Cancer Found During Preoperative Screening

Patient Info: Anonymized, Female | Stage III

Biomarkers: BRCA1 pathogenic variant on homologous recombination deficiency testing; germline BRCA1 pathogenic variant

At approximately 1 year after surgery, she was alive without evidence of recurrence while continuing olaparib and bevacizumab maintenance therapy.

PubMed CentralRead more →

Growing Masses After Chemotherapy for an Ovarian Germ Cell Tumor

Patient Info: Anonymized, Female, Under 40

Biomarkers: AFP 581.2 ng/mL and CA-125 74.3 U/mL after surgery

Despite 6 chemotherapy cycles and normalization of AFP, abdominal and pelvic masses continued to grow while CA-125 and CEA increased. She sought a second opinion and underwent imaging and biopsy of an abdominal mass.

PubMed CentralRead more →

Recurrent Malignant Ovarian Steroid Cell Tumor Treated With Multiple Therapies

Patient Info: Anonymized, Female

Biomarkers: PIK3CA, and ATM mutations; ER negative; PR negative

She experienced repeated pelvic and lung recurrences. Platinum-based treatment produced a complete PET-CT response and olaparib maintenance provided about 1 year without progression before a 5 mm lung recurrence was surgically removed.

PubMed CentralRead more →

Stage III Ovarian Cancer During Care for Common Variable Immunodeficiency

Patient Info: Anonymized, Female | Stage III

She remained alive on maintenance bevacizumab, with no radiologic evidence of ovarian-cancer progression.

PubMed CentralRead more →

Malignant Struma Ovarii Managed With Surgery and Long-Term Surveillance

Patient Info: Anonymized, Female

Biomarkers: BRAF mutation negative

She remained asymptomatic with thyroid-stimulating hormone at the treatment goal and entered long-term thyroglobulin surveillance.

PubMed CentralRead more →

Stage IIIC Primary Ovarian Leiomyosarcoma Treated With Debulking Surgery and Chemotherapy

Patient Info: Anonymized, Female | Stage III

Biomarkers: SMA positive; caldesmon positive; Ki-67 15%–20%; p53 negative

She recovered from extensive cytoreductive surgery, reported resolution of her symptoms, and began planned adjuvant Adriamycin and ifosfamide.

PubMed CentralRead more →

Stage III BRCA Ovarian Cancer: Mimi's Survivor Story

Patient Info: Mimi Gallagher, 40s | Stage III

Biomarkers: BRCA-positive

Mimi was cancer-free after surgery and 4 months of intraperitoneal chemotherapy, completed in December 2012.

Dana-FarberRead more →

Ovarian Cancer Can Present Unique Challenges Around Gender

Patient Info: Anonymized, 40s

At annual follow-up, the ovarian cancer remained in remission with no recurrences since treatment ended in December 2009.

Dana-FarberRead more →

Stage III Ovarian Cancer: Margaret's Patient Story

Patient Info: Margaret Winchester | Stage III

Margaret experienced recurrent small ovarian tumors, underwent cryoablation, and had recently completed another clinical trial while continuing her work.

Dana-FarberRead more →

Ovarian Cancer: Faye's Patient Story

Patient Info: Faye Belvin, Female

Faye was still receiving the trial combination and said the treatment was working and that she felt better than she had in the previous 2 years.

Metastatic Follicular Carcinoma Arising From Struma Ovarii

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: right fallopian tube|peritoneum|omentum|bladder…

Four years after diagnosis, she had no evidence of recurrence or metastasis while continuing thyroid-hormone suppression and 6-monthly surveillance.

PubMed CentralRead more →

Recurrent Ovarian Cancer and Olaparib-Related Skin Toxicity

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|liver

The latest chemotherapy was effective, and she was alive without signs of another recurrence at the last documented follow-up.

PubMed CentralRead more →

Stage III Ovarian Cancer: Karen's Survivor Story

Patient Info: Karen Howley LaCamera, 50s | Stage III

The REGN4018 clinical trial put Karen’s ovarian cancer into remission, which had lasted nearly a year when the story was written, with follow-up every 6 weeks.

Dana-FarberRead more →

Ovarian Cancer Metastasis to the Cervical Spinal Canal

Patient Info: Anonymized, Female, 70+ | Stage Metastatic/Advanced

Metastatic Site: brain|cervical intradural extramedullary space

Her neck and shoulder pain resolved after spinal surgery, but she developed recurrent brain disease and died from cachexia 4 months after the spinal operation.

PubMed CentralRead more →

Stage IV ovarian cancer complicated by a spontaneous vaginal fistula

Patient Info: Anonymized, Female, 50s | Stage IV

After postoperative chemotherapy, she was clinically well and imaging showed no visible tumor during 8 months of follow-up.

PubMed CentralRead more →

Ovarian Granulosa Cell Tumor Recurring 17 Years After Surgery

Patient Info: Anonymized, Female, 70+

Biomarkers: Weak oestrogen sensitivity

Complete resection was not possible, but debulking relieved pressure on surrounding structures and improved her quality of life. She then continued oncology care with palliative carboplatin and paclitaxel.

PubMed CentralRead more →